Report finds PBMs are increasingly restricting patient access to medicines

More than 1,150 medicines were excluded from at least one of the three largest PBMs ’ standard commercial formularies in 2022, according to a newreport from Xcenda. The report is further evidence of how PBMs are making it harder for patients to get the prescription medicines they need.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Access Drug Cost Health Insurance Source Type: news